Similar to CSF p-tau, plasma p-tau has been found to increase in AD compared to MCI, non-AD dementias and cognitively unimpaired controls (Shekhar et al., 2016; Tatebe et al., 2017; Janelidze et al., 2020; Karikari et al., 2020b). This evidence concerns the gene MAPT and Alzheimer disease.